Cochlear Limited (COH.AX)
| Previous close | 255.27 |
| Open | 256.35 |
| Bid | 255.31 x 10000 |
| Ask | 255.43 x 3400 |
| Day's range | 255.16 - 257.28 |
| 52-week range | 184.62 - 274.65 |
| Volume | |
| Avg. volume | 142,997 |
| Market cap | 16.75B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | 55.87 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.50 (1.37%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | N/A |
- PR Newswire
Cochlear™ Osia® System becomes industry's first active bone conduction system to enable MRI at 3 Tesla
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces its next generation Cochlear™ Osia® System with the ability to have an MRI at 3.0 T, designed to improve hearing outcomes for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD).
- PR Newswire
Hearing loss in global spotlight as technology and research leaders collaborate to tackle rising impact, and experts unite to demystify care
According to the World Health Organization (WHO), the number of people living with hearing loss is set to reach 2.5 billion by 2050.1 Now, leading technology companies, researchers, and people living with hearing loss are coming together to tackle its rising impact.
- PR Newswire
Cochlear announces 2023 winners of annual scholarships
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 21st annual Graeme Clark, the 12th annual Anders Tjellström, and 1st annual Vocational Scholarships. The Academic Scholarships are named after two pioneers of the hearing implant industry and recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and dem
